Article
Mar 13, 2026
Schizophrenia: Symptoms, Diagnosis, Care, and Scientific Advances
Understand schizophrenia, its symptoms, and the scientific advances that help patients and families cope with the disorder in a safe and humane way.
Schizophrenia is a mental health condition that affects millions of people worldwide, altering the way they think, perceive reality, express emotions, and relate to others.
For many, the diagnosis brings questions, fears, and isolation. But there is also room for hope: with specialized medical support, therapeutic assistance, and a sensitive support network, it is possible to live with quality, construct meaning, and regain affected functions.
Today's article is prepared for you who live with schizophrenia - or for those who care for someone diagnosed - seeking to clarify what schizophrenia is, what can cause it, its symptoms, types, diagnosis, scientific advancements, care, and support.
Our goal is to inform with empathy, responsibility, and real data, always drawn from internationally relevant medical sources - which can be found and consulted in the footer of this article. Happy reading.
What is schizophrenia?
Schizophrenia is classified as a chronic mental disorder that impacts cognitive, social, and emotional functioning. It is characterized by psychotic episodes but also by less visible symptoms, such as cognitive or emotional deficits.
According to the World Health Organization (WHO), approximately 24 million people live with schizophrenia worldwide, which corresponds to about 0.32% of the global population.
The National Institute of Mental Health (NIMH) estimates a prevalence of around 0.25% to 0.64% in the U.S. for schizophrenia and related psychotic disorders, when considering well-structured clinical diagnoses.
Schizophrenia is usually identified in late adolescence or early adulthood, although subtle signs may appear much earlier.
Each case of schizophrenia is unique: the type of symptoms, their intensity, persistence, response to treatment, and impact on social life, work, or studies vary.
Therefore, understanding what schizophrenia is involves observing the symptoms, timing, abilities, and desires of each person.
Possible causes and factors
Recent medical research suggests that what can cause schizophrenia is a combination of elements, never a single isolated reason.
Genetic factors play an important role: having a first-degree relative with schizophrenia significantly increases the risk. Genes associated with neurotransmitters, brain development, and stress response are under active study.
From a biological perspective, imbalances in neurotransmitter systems - dopamine, glutamate, serotonin - and structural brain changes are frequently observed.
Perinatal events, viral infections during pregnancy, and complications during birth have also been related to a greater risk of later developing schizophrenia.
Finally, environmental and psychosocial factors help trigger schizophrenia in vulnerable individuals: early use of Cannabis or other psychoactive substances, trauma (abuse, neglect), social stigma, ongoing stress, and lack of social support. There are no culprits or simple causes - there are contexts, risks, and vulnerabilities.
Symptoms of schizophrenia
The symptoms of schizophrenia can vary greatly from one person to another, both in intensity and duration. This disorder affects the way the individual thinks, feels, and perceives the world around them.
Often, what is noticed is a disconnection between thought and reality - a complex neurobiological alteration, requiring comprehension, diagnosis, and specialized medical follow-up.
According to the National Institute of Mental Health (NIMH), schizophrenia affects about 24 million people globally, which corresponds to approximately 1 in every 300 adults.
Although symptoms and signs generally appear in late adolescence or early adulthood, they may remain silent for some time until they manifest more evidently. Therefore, it is essential for family members and support networks to pay attention to subtle changes in behavior, cognition, and routine.
Science often groups the symptoms of schizophrenia into three main categories: positive, negative, and cognitive. Each group reflects a different aspect of brain functioning and human experience, and understanding these differences is important to break stigma and offer support.
Positive symptoms
Positive symptoms involve alterations in the perception of reality, causing the individual to see, hear, and believe things that are not shared by others.
These symptoms do not represent a lack of lucidity or willpower, but rather a dysfunction in the processing of information in the brain - especially in the areas responsible for interpreting external stimuli. The main psychotic symptoms include:
Hallucinations: sensory perceptions without external stimuli, such as hearing voices that do not exist or seeing non-existent images. Auditory hallucinations are the most common.
Delusions: firm and unwavering beliefs in ideas that do not correspond to reality, such as feeling persecuted or believing one has special powers.
Disorganized thinking: difficulty maintaining a coherent line of thought, reflected in confused speech, unusual associations, or loss of focus.
Disorganized motor behavior: agitation, repetitive movements, or inappropriate emotional responses to the context.
These symptoms can generate fear, confusion, and social isolation, but with medical follow-up, it is possible to stabilize them and restore a functional and dignified life to the person.
Negative symptoms
Negative symptoms are linked to a reduction or absence of psychological functions considered "normal" in everyday life. They are symptoms that often go unnoticed by family and professionals but have a significant impact on quality of life.
They represent, largely, an emotional and motivational disconnect - something that is often confused with laziness, disinterest, or coldness, when in fact, it is a direct result of the disorder.
Among the main negative symptoms of schizophrenia are:
Apathy: significant reduction in energy and motivation, leading to difficulty in starting or completing simple tasks.
Anhedonia: inability to feel pleasure in activities that were previously considered enjoyable.
Poverty of speech: short responses or absence of spontaneity in verbal communication.
Social isolation: gradual distancing from friends, family, and communal environments.
Blunted affect: reduced emotional expression, even in situations that would normally evoke joy, sadness, or empathy.
These symptoms are especially challenging because they can be mistaken for personality traits, delaying diagnosis and the start of appropriate care. Recognizing them is essential to reduce the silent suffering of those living with schizophrenia.
Cognitive symptoms
Cognitive symptoms of schizophrenia relate to how the brain processes, organizes, and uses information. They are responsible for difficulties in maintaining focus, planning tasks, or making decisions - critical executive functions needed for daily life.
Even though they are less visible, these symptoms are one of the main reasons why specialized follow-up is indispensable, as they directly impact the individual's autonomy and social integration.
The most common cognitive symptoms include:
Attention deficit: difficulty in maintaining concentration during continuous activities, such as reading, studying, or following long conversations.
Memory problems: forgetting recent information or difficulty retaining new learning.
Slow reasoning: reduction in mental processing speed, making simple tasks take longer.
Planning difficulties: impairment of executive functions that affect the ability to organize daily routines and handle responsibilities.
Lack of insight: difficulty in recognizing one’s own condition and perceiving the need for professional guidance.
Over time, these symptoms can hinder academic, professional, and social performance, but there are therapeutic approaches - such as cognitive rehabilitation and psychosocial support - that help restore some of these skills, strengthening the recovery and reintegration process.
Schizophrenia: early symptoms
Before the confirmation of a diagnosis, many signs of schizophrenia gradually appear. Recognizing these symptoms can allow for more assertive interventions. Continue reading to learn about some:
Behavioral or social change: withdrawal from social interactions, reduced communication with family or close people.
Lack of interest or neglect of personal or occupational matters: work, school, personal hygiene, or daily habits.
Changes in sleep or appetite: persistent insomnia, fragmented sleep, unexplained weight gain or loss.
Fluctuations in mood: irritability, sadness, frequent anxiety crises.
Atypical thoughts: poorly organized ideas, strange perceptions, or unusual worries without firm delusions.
These early symptoms do not guarantee that schizophrenia will develop but signal the need for evaluation by a specialized professional.
When does schizophrenia manifest?
The manifestation of schizophrenia usually occurs between the ages of 16 and 30, a period when the brain is still undergoing intense development. In men, the onset tends to be slightly earlier, generally in late adolescence, while in women it occurs more frequently in early adulthood.
This difference may be related to hormonal and neurobiological factors that influence dopaminergic functioning and brain maturation.
Before the formal diagnosis, it is common to observe some subtle signs that may go unnoticed:
decline in academic performance;
social isolation;
irritability;
difficulties in concentration;
behavioral changes.
This stage, known as the prodromal phase, can last for months or even years. Recognizing these early signs and seeking professional help as soon as possible is recommended to reduce the impact of the disorder and promote a better treatment response.
Diagnosis of schizophrenia
The diagnosis of schizophrenia is performed by psychiatrists and specialized teams and requires careful clinical analysis, history of symptoms, exclusion of other conditions (organic, neurological, substance use), and application of diagnostic criteria such as DSM-5.
Does schizophrenia have a cure?
The truth is that, so far, there is no scientific evidence of a definitive cure for schizophrenia. Longitudinal studies show that many patients achieve remission of significant symptoms - that is, reduction or disappearance of psychotic symptoms or functional impact - when receiving appropriate treatment.
What are Longitudinal Studies? Research that follows and observes the same individuals or a specific group repeatedly over a long period of time to analyze changes in specific variables.
For example, a study of 3 years with previously untreated patients showed that about 60.3% achieved remission of symptoms, 45.4% functioned well socially, and 51.7% met the criteria for "partial" or functional "recovery."
Still, the criteria for "full recovery" (which include prolonged remission + stable social functioning) were much less frequent.
In another meta-analysis involving individuals with their first episode of schizophrenia or related psychotic disorders, after an average of 9.5 years of follow-up, the clinical recovery rate was around 20.8%.
In other words, while there is no guaranteed cure, there is a genuine possibility of lasting improvements, regaining autonomy, participating socially, and engaging in employment or education.
Scientific advancements for schizophrenia
Scientific advancements in the field of schizophrenia have been transforming the understanding and management of this complex disorder. In the last two decades, genetic, neurobiological, and pharmacological studies have provided new perspectives on brain functioning and the underlying causes of the disease.
Treatments
The treatment of schizophrenia is continuous and comprehensive, involving pharmacological, psychosocial, and rehabilitation interventions. The goal is to reduce symptoms, prevent relapses, and promote the social and functional reintegration of the person.
The appropriate combination of medication, therapeutic support, and rehabilitation strategies tends to yield the best clinical outcomes, especially when the follow-up is regular and personalized.
According to the MSD Manual - Professional Version (MSD Manuals, 2024), the main pillars of treatment include:
Antipsychotic drugs: they are the foundation of schizophrenia management, helping to control hallucinations, delusions, and thought disturbances. Continuous use, under medical supervision, is associated with a reduction in relapses and hospitalizations.
Rehabilitation: involves structured programs that promote the development of social, cognitive, and professional skills, including community training and support services to foster autonomy and reintegration.
Psychotherapy: serves as a necessary complement to medication treatment, enhancing therapeutic adherence, emotional resilience, and coping strategies in the face of daily challenges.
The recommended treatment is one that combines evidence-based medical interventions with an integrated support network to ensure stability, dignity, and better quality of life for the person.
Clinical research
Clinical research on schizophrenia plays a profoundly necessary role in the evolution of scientific knowledge and the enhancement of available treatments.
It is through rigorously controlled studies that scientists and health professionals evaluate new therapeutic approaches, medications, and psychosocial interventions, always under ethical and medical supervision.
Participating in clinical research is synonymous with conscious involvement in a process that contributes to the advancement of science and the future of mental health care.
These investigations are regulated by organizations such as Anvisa, the Research Ethics Committee (CEP), and follow international safety standards defined by the ICH-GCP.
Would you like to know more about the benefits of clinical research for the treatment of schizophrenia? Click here.
Care and support
Managing schizophrenia requires much more than medication. It also involves a care network, a welcoming environment, and well-formed strategies that promote security, self-esteem, and dignity.
According to the World Health Organization (WHO), programs that combine psychosocial rehabilitation, family education, and community support significantly reduce relapses and improve therapeutic adherence.
Caring for someone with schizophrenia is a joint process - involving healthcare professionals, family members, caregivers, and the person in treatment themselves - with the greater goal of promoting autonomy and quality of life in a continuous and sustainable manner.
When and how to seek help?
Living with schizophrenia - whether as a patient, family member, or caregiver - is to deal daily with challenges that are not always understood. Among adjustments in routine, doubts about the future, and the search for stability, many people feel alone on this journey.
The clinical research of Synvia exists so that new possibilities can be studied, always under strict medical supervision and at no financial cost.
By participating, you help science better understand schizophrenia while receiving specialized attention in a safe and supervised environment.
This is an invitation to transform your experience into impact - for yourself and for many others who share the same diagnosis. Click the button below to discover how to participate in Synvia's clinical research.
________________________________________________________________________________________________________
References
AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). 5th ed. Arlington, VA: American Psychiatric Publishing, 2022.
WORLD HEALTH ORGANIZATION. Schizophrenia fact sheet. 2024. Available at: https://www.who.int/news-room/fact-sheets/detail/schizophrenia.
NATIONAL INSTITUTE OF MENTAL HEALTH. Schizophrenia. 2024. Available at: https://www.nimh.nih.gov/health/topics/schizophrenia.
LAM, B.; NABER, D.; SCHACHT, A. et al. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatrica Scandinavica, v. 118, n. 3, p. 220-229, 2008. Available at: https://pubmed.ncbi.nlm.nih.gov/18699954.
ALAQEEL, B. Remission in schizophrenia: critical and systematic review. Schizophrenia Research, 2012. DOI: 10.1016/j.schres.2012.01.021. Available at: https://pubmed.ncbi.nlm.nih.gov/23216066.
MOSOLOV, S. N.; POTAPOV, A. V.; USHAKOV, U. V. Remission in schizophrenia: results of cross-sectional with 6-month follow-up period and 1-year observational therapeutic studies in an outpatient population. Annals of General Psychiatry, v. 11, art. 1, 2012. Available at: https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/1744-859X-11-1.
TARGUM, S. D.; LIEBERMAN, J. A. et al. Efficacy and safety of xanomeline-trospium chloride in schizophrenia: results from the EMERGENT-2 trial. The Lancet, v. 403, n. 10413, p. 1410–1420, 2024. Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02190-6/fulltext.
JAMA PSYCHIATRY. Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia (EMERGENT-3). JAMA Psychiatry, 2024. DOI: 10.1001/jamapsychiatry.2024.0721. Available at: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2818047.
UNITED STATES NATIONAL LIBRARY OF MEDICINE. Targeting muscarinic receptors in schizophrenia treatment: novel approach. PubMed Central (PMC), 2024. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12188895.
ANDREASSEN, O. A.; OLSEN, L. et al. Advances in understanding and treating schizophrenia. Nature Reviews Disease Primers, v. 9, art. 23, 2023. Available at: https://www.nature.com/articles/s41572-023-00423-3.
VAN OS, J.; KAPUR, S. Schizophrenia. The Lancet, v. 374, n. 9690, p. 635–645, 2009. Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60995-8/fulltext.
RESEARCHGATE. Proposed criteria for schizophrenia remission. BMC Psychiatry, v. 7, art. 35, 2007. Available at: https://www.researchgate.net/publication/262020997_Proposed_criteria_for_schizophrenia_remission.
SCHIZOPHRENIA INTERNATIONAL RESEARCH SOCIETY (SIRS). 2023 Global Report on Schizophrenia Research Advances. Available at: https://www.schizophreniaresearchsociety.org.